Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1989-06-22
1992-01-21
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
424 4, 436173, 436806, 514492, 514836, 514974, G01N 3100, G01N 2400, A61K 3128
Patent
active
050826492
ABSTRACT:
Paramagnetic chelates, as for example, Gadolinium diethylenetriaminepentaacetic acid (DTPA), manganese, ethylenediaminetetraacetic acid (EDTA), and others used as magnetic resonance imaging contrast agents are more toxic acutely when injected in high concentration or at rapid rates. The use of effective amounts of calcium in the form of, calcium chloride, calcium gluconate, or balanced salt solutions substantially reduces this toxicity without the need to add additional ligand.
REFERENCES:
patent: 4478816 (1984-10-01), Ledley et al.
patent: 4647447 (1987-03-01), Gries et al.
patent: 4822594 (1989-04-01), Gibby
Hollinden Gary E.
Hollrah Glennon H.
Mallinckrodt Medical Inc.
LandOfFree
Method for enhancing the safety of metal-ligand chelates as magn does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for enhancing the safety of metal-ligand chelates as magn, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for enhancing the safety of metal-ligand chelates as magn will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-114320